Cologne Cohort of Neutropenic Patients (CoCoNut)

Sponsor

University Hospital of Cologne (Other)

Overall Status

Recruiting

CT.gov ID

NCT01821456

Collaborator

(none)

100,000

Enrollment

Location

671

Duration (Months)

149

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The Cologne Cohort of Neutropenic Patients (CoCoNut) is a non-interventional cohort study assessing risk factors, interventions, and outcome of immunosuppressed patients with or without opportunistic infections.

Condition or Disease	Intervention/Treatment	Phase
Hematological Malignancies Cancer Chemotherapy Neutropenia Immunosuppression	Drug: Antiinfectives

Detailed Description

This prospective cohort was established with the aim of a comprehensive data collection of all patients developing neutropenia after receiving chemotherapy for any kind of malignant disease, treated in the University Hospital of Cologne.

Study Design

Study Type:

Observational

Anticipated Enrollment :

100000 participants

Observational Model:

Cohort

Time Perspective:

Prospective

Official Title:

The Cologne Cohort of Neutropenic Patients (CoCoNut) - a Non-interventional Cohort Study Assessing Risk Factors, Interventions, and Outcome of Immunosuppressed Patients With or Without Opportunistic Infections

Study Start Date :

Jan 1, 1995

Anticipated Primary Completion Date :

Dec 1, 2050

Anticipated Study Completion Date :

Dec 1, 2050

Arms and Interventions

Arm	Intervention/Treatment
Antiinfectives To analyze the efficacy of antiinfectives at high risk patients	Drug: Antiinfectives To analyze to efficacy of (novel) drug therapies Other Names: Antifungals, Antibacterials, Antivirals

Arm

Intervention/Treatment

Antiinfectives

To analyze the efficacy of antiinfectives at high risk patients

Drug: Antiinfectives

To analyze to efficacy of (novel) drug therapies

Other Names:

Antifungals, Antibacterials, Antivirals